Pesce, A. “Why Pharmacogenetic Testing Should Be Reimbursed by Medicare and Commercial Health Insurance”. Journal of Opioid Management, vol. 20, no. 4, Aug. 2024, p. 267, doi:10.5055/jom.0870.